Research ArticleArticle
Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug
Jonathan N. Bauman, Kosea S. Frederick, Aarti Sawant, Robert L. Walsky, Loretta M. Cox, Ronald S. Obach and Amit S. Kalgutkar
Drug Metabolism and Disposition June 2008, 36 (6) 1016-1029; DOI: https://doi.org/10.1124/dmd.108.020545
Jonathan N. Bauman
Kosea S. Frederick
Aarti Sawant
Robert L. Walsky
Loretta M. Cox
Ronald S. Obach
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug
Jonathan N. Bauman, Kosea S. Frederick, Aarti Sawant, Robert L. Walsky, Loretta M. Cox, Ronald S. Obach and Amit S. Kalgutkar
Drug Metabolism and Disposition June 1, 2008, 36 (6) 1016-1029; DOI: https://doi.org/10.1124/dmd.108.020545
Research ArticleArticle
Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug
Jonathan N. Bauman, Kosea S. Frederick, Aarti Sawant, Robert L. Walsky, Loretta M. Cox, Ronald S. Obach and Amit S. Kalgutkar
Drug Metabolism and Disposition June 1, 2008, 36 (6) 1016-1029; DOI: https://doi.org/10.1124/dmd.108.020545
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement